Donate

Lung Cancer Clinical Trials

What they are, why they matter, how they expand treatment options, and how to take the next step.

Lung cancer clinical trials can offer access to cutting‑edge therapies and help improve treatment availability for everyone. Learn what they are, why representation matters, and how to talk with your care team about enrolling.

What Are Clinical Trials?

Clinical trials are highly monitored research studies that test new ways to prevent, detect, diagnose, or treat lung cancer. Every participant receives the highest standard of care; no one is given a placebo instead of treatment. 

Key points:

  • Clinical trials evaluate new treatments or combinations of multiple treatments (e.g., chemotherapy + immunotherapy).
  • Participants are closely monitored for safety and effectiveness.
  • Trials may offer access to promising therapies not yet widely available.
  • Participation contributes to future breakthroughs and helps others.

Phases of a Clinical Trial:


GoalParticipantsFocus

Phase 1

Assess safety

20-100 healthy volunteers

Safe dosage range
Side effects

Phase 2

Evaluate effectiveness

100-300 patients with the condition

Does it work?
What are the short-term risks?

Phase 3

Confirm effectiveness at scale

1,000-3,000+ patients

Compare to standard treatments
Monitor adverse reactions

Phase 4

Long-term monitoring after approval

Thousands

Real-world safety
Long-term effects
Rare side effects

Why Clinical Trials Matter in Lung Cancer

Lung cancer remains the leading cause of cancer deaths in the U.S., but research is rapidly advancing. Every treatment available for lung cancer began in a clinical trial. Today, more than 70 new treatments have been approved since 2016, and clinical trials are essential to continuing this progress.

Key points to understand the value of clinical trials:

Better Treatments

Trials help researchers understand which therapies work best.

Earlier Detection

Research drives improvements in screening and biomarker testing.

Personalized Medicine

Trials help refine targeted therapies based on tumor genetics.

Quality of Life

Studies also explore supportive care and survivorship.

Importance of Diversity in Clinical Trials

Clinical trials must include people from all backgrounds to ensure treatments work for everyone. That way researchers can learn about how lung cancer treatments work in different populations. This extends treatment options for not only people enrolled in the trial, but for current and future lung cancer patients.

Unfortunately, clinical trial enrollment in the U.S. may not fully resemble the makeup of the population. Yet many communities remain underrepresented. This is true for several reasons. One of them is the long-standing history of racial bias in healthcare which impacts access to care and trust in providers.

Black men in particular suffer disproportionally from lung cancer. Black men are more likely to get lung cancer and die from it than their white counterparts, despite historically lower smoking rates. 

Black Americans with lung cancer are less likely to be diagnosed at an early stage, less likely to receive surgical treatment, and less likely to receive any treatment at all compared to white Americans. This leads to poorer outcomes from lung cancer for Black Americans.

But there is hope. Lung cancer research is moving at a rapid pace. We are learning more about how lung cancer develops, and researchers are working hard to find treatments to help save and extend the lives of lung cancer patients. Sometimes the most appropriate treatment option for a lung cancer patient is a clinical trial. 

Learn why clinical trial enrollment matters and see how you can help shape the future of lung cancer treatment.

Read the Blog: The Importance of Representation in Lung Cancer Clinical Trials | American Lung Association

While progress in the early detection and treatment of the disease in recent years has been made, this progress has not been shared equally, and lung cancer disparities continue to impact the Hispanic community.

Currently, Hispanic individuals with lung cancer are 16% less likely to be diagnosed early and are 30% more likely to not receive any treatment.  Lung cancer research is moving at a rapid pace, and clinical trials are critical to advancing promising lung cancer treatments. However, only 1% of the clinical trial population is represented by Hispanics.   

There is hope, and Hispanic individuals deserve to benefit from the cutting-edge therapies clinical trials may offer as clinical trials are sometimes the most appropriate treatment option for a lung cancer patient. Participating in a clinical trial might give you access to cancer care that could save or extend your life. That means more precious time with your loved ones. When you participate in a clinical trial, not only are you accessing high-quality cancer care, but you are also contributing to cancer research which might save someone’s life in the future.

Listen to personal stories on the benefits of clinical trials.

Learn why clinical trial enrollment matters and see how you can help shape the future of lung cancer treatment.

Get information on Clinical Trials in Spanish

What to Expect When Joining a Clinical Trial

Enrollment Process

How Enrollment Works: 

Referral

Screening

Informed Consent

Treatment Plan

Referral Process

Not everyone is eligible to participate in a clinical trial. Before joining a clinical trial, you must qualify for the study by meeting certain "criteria" and speaking with your doctor about the clinical trial so they can refer you or help with finding the best one for you. These criteria can include age, gender, the type and stage of your disease, as well as your previous treatment history and other medical conditions. The criteria are different for each clinical trial.  

Clinical trials participants should include individuals from all backgrounds.

Your Rights and Safety

Your Rights

Clinical trials are carefully monitored research studies. Participation is voluntary with the ability to withdraw at any time, for any reason.

Safety Measures 

Oversight by medical teams, ethics boards, and federal regulators.

Clinical trials receive oversight from the medical teams and researchers in a variety of locations, including hospitals, universities, doctors' offices, or community health clinics. 

Institutional Review board (IRB)

Every clinical trial in the U.S. must be approved and monitored by an Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits. The physicians, statisticians, patient advocates, and other members of the community that make up the IRB ensure the study is ethical and that you are not likely to be harmed. The IRB can stop a study if:

  • It appears to be causing unexpected harm to participants
  • There is evidence that the risks outweigh the benefits
  • There is clear evidence that the new treatment is effective (If this is the case, the goal is to stop the trial and make the treatment more widely available)
Costs & Coverage

Costs & Coverage 

  • Many trials cover treatment‑related costs; it is important to discuss specifics with your care team.
  • The study may require a lot of time for traveling to the study site, receiving treatments, or hospital stays
  • Your health insurance may not cover all of the study costs outside of treatment. 

Talk with your care team to learn more about cost and coverage.

Risks and Benefits

Risks and Benefits

There are both benefits and risks associated with clinical trials.

Potential Benefits

  • You and your health care provider believe a clinical trial may provide another option when standard treatments have failed. 
  • You want to help test new or newly applied medical products or therapies.
  • You want to help researchers find better ways to fight diseases.

Possible Risks

  • There may be unpleasant, serious or even life-threatening side effects from treatment.
  • Treatment may not be effective for some individuals.
  • You may need to relocate to the treatment site for appointments and monitoring. 
  • You may be hospitalized.

How to Talk to Your Doctor About Clinical Trials

Lung cancer treatment decisions, like clinical trials, can be complicated and sometimes difficult to understand. To help you understand if clinical trials are right for you, use the suggested questions to guide your conversation with your doctor

  • What trials are available for my type and stage of lung cancer?
  • What are the potential benefits and risks of the trial?
  • What are the side effects?
  • How will this affect my current treatment?
  • What tests or visits are required?
  • Will I incur any out-of-pocket costs?
  • How long does the trial last?
  • What happens if I leave the trial early?

Finding a Trial

Your doctor may be able to help you find a clinical trial. You can also search for clinical trials online. 

The American Lung Association wants our patient and caregiver visitors to be aware of the following clinical trial programs:

Find a Clinical Trial

Learn more about clinical trial programs in your area by searching the American Lung Association clinical trial list.
View Trials

Page last updated: June 3, 2026

Tobacco Basics
, | Jun 24, 2026
LUNG FORCE Walk - Cleveland
Cleveland, OH | Sep 27, 2026